REVIEW ARTICLES

Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib
Bogdan Gafton, Vlad Porumb, Simona Ungurianu, Mihai Vasile Marinca, Corina Cocea, Adina Croitoru, Gheorghe Balan, Nicolae Miron, Tudor Eliade Ciuleanu, Lucian Miron; pp 858-866 (Pubmed Abstract, PDF)

Immunotherapy for hepatocellular carcinoma following thermal ablation
Xin Li, Ping Liang; pp 867-871 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

BREAST CANCER

Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey
Burcin Budakoglu, Kadri Altundag, Sercan Aksoy, Muhammed A Kaplan, Nuriye Y Ozdemir, Veli Berk, Metin Ozkan, Efnan Algin, Nurten Kandemir, Gamze G Dogu, Hakan Harputluoglu, Ulku Y Arslan, Ugur Coskun, Abdurrahman Isikdogan, Berna Oksuzoglu; pp 872-878 (Pubmed Abstract, PDF)

Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
Bala Basak Oven Ustaalioglu, Fugen Aker Vardar, Ahmet Bilici, Gunay Gurleyik, Burcak Erkol, Umut Kefeli, Mehmet Aliustaoglu; pp 879-886 (Pubmed Abstract, PDF)

Survey on Chinese breast cancer patients’ husbands toward breast conserving surgery
Li Zhang, Yi Zhou, Rong Fu, Xiao-bo Du, Wen-xiu Yao, Li-qun Zou; pp 887-894 (Pubmed Abstract, PDF)

Micronuclei and other nuclear anomalies in exfoliated buccal mucosa cells of Mexican women with breast cancer
Aurelio Flores-García, Olivia Torres-Bugarín, Jesús Salvador Velarde-Félix, Héctor Rangel-Villalobos, Eloy Alfonso Zepeda-Carrillo, Amelia Rodríguez-Trejo, Pedro Aguíar-García, Armen Nersesyan; pp 895-899 (Pubmed Abstract, PDF)

PTEN loss is not associated with trastuzumab resistance in metastatic breast cancer
Muharrem Kocar, Emine Bozkurtlar, Ferhat Telli, Nazim Serdar Turhal, Handan Kaya, Hande Kocar, Fulden Yumuk; pp 900-905 (Pubmed Abstract, PDF)

COLORECTAL CANCER

Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinoma
Burak Civelek, Sercan Aksoy, Mehmet Ali Nahit Sendur, Ozan Yazici, Huseyin Kanmaz, F. Tugba Kos, Nuriye Yildirim, Dogan Uncu, Nurullah Zengin; pp 906-912 (Pubmed Abstract, PDF)

Quality assessment of decision–making in colorectal cancer multidisciplinary team meetings
Charalampos Seretis, Rajnish Mankotia, Kolitha Goonetilleke, Edward Rawstorne; pp 913-916 (Pubmed Abstract, PDF)

Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: A meta-analysis
Cui Chen, Peng Sun, Sheng Ye, Hui-wen Weng, Qiang-sheng Dai; pp 917-924 (Pubmed Abstract, PDF)

Effect of Bcl-xL gene expression silenced by RNA interference on invasion of human colorectal cancer cells
Wei-Dong Liu, Yan-Zhi Bo, Yu Fan, Kun Wu, Cheng-Cheng Gao, Tian-Fang Xia, Zhen-Shen Qing, Li-Qun Pang; pp 925-929 (Pubmed Abstract, PDF)

HEAD AND NECK CANCER

Phase II clinical trial of h-R3 combined with radiotherapy in locally advanced nasopharyngeal carcinoma
Ren-Rui Wu, Zhen-Yu Xiao, Chen Wang, Hua-Feng Liu, Hao Zhong, Feng Li; pp 930-936 (Pubmed Abstract, PDF)

Pretreatment perfusion CT and CT volumetry in squamous cell carcinoma of the head and neck region
Katarina Surlan Popovic, Snezana Lukic, Peter Popovic; pp 937-943 (Pubmed Abstract, PDF)

Clinical significance of Cyclin D1, FGF3 and p21 protein expression in laryngeal squamous cell carcinoma
Ivan P. Jovanovic, Gordana D. Radosavljevic, Bojana J. Simovic-Markovic, Stevan P. Stojanovic, Srdjan M. Stefanovic, Nada N. Pejnovic, Nebojsa N. Arsenijevic; pp 944-952 (Pubmed Abstract, PDF)

Dosimetric evaluation of nasopharyngeal carcinomas irradiated with different IMRT techniques
Sevim Ozdemir, Yasin Coban, Mustafa Akin, Pınar Ambarcıoglu, Ozgehan Onay, Cumhur Yıldırım, Esengul Uzel, Omer Uzel; pp 953-957 (Pubmed Abstract, PDF)

GYNECOLOGICAL CANCER

Tissue expression of VEGF in cervical intraepithelial neoplasia and cervical cancer
Aljosa Mandic, Slavica Usaj Knezevic, Tatjana Kapicl Ivkovic; pp 958-964 (Pubmed Abstract, PDF)

Systematic evaluation of bevacizumab in recurrent ovarian cancer treatment
Shan-Shan Ding, Li Li, Chun-Xia Yu; pp 965-972 (Pubmed Abstract, PDF)

Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination?
Emina Malisic, Ksenija Brotto, Ana Krivokuca, Milena Cavic, Radmila Jankovic; pp 973-979 (Pubmed Abstract, PDF)

Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer
Mukremin Uysal, Mustafa Ozdogan, Aysegul Kargi, Seyda Gunduz, Sema Sezgin Goksu, Ali Murat Tatli, Deniz Arslan, Hasan Mutlu, Hasan Senol Coskun, Hakan Bozcuk; pp 980-984 (Pubmed Abstract, PDF)

HEMATOLOGICAL MALIGNANCIES

JAK2V617F mutation and endogenous erythroid colony formation in patients with polycythaemia vera
Milica Strnad, Biljana Todoric Zivanovic, Zeljka Tatomirovic, Olivera Tarabar, Marija Elez, Olga Radic, Dragana Stamatovic; pp 985-991 (Pubmed Abstract, PDF)

Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes
Bakiye Goker, Cansu Caliskan, Hasan Onur Caglar, Cagla Kayabasi, Tugce Balci, Burcu Erbaykent Tepedelen, Duygu Aygunes, Sunde Yilmaz Susluer, Zeynep Mutlu, Nur Selvi Gunel, Mehmet Korkmaz, Guray Saydam, Cumhur Gunduz, Cigir Biray Avci; pp 992-998 (Pubmed Abstract, PDF)

Myelodysplastic syndromes in adults aged less than 50 years: Incidence and clinicopathological data
Dragomir Marisavljevic, Aleksandar Savic, Vanja Zeremski, Natasa Stanisavljevic, Svetlana Jelic; pp 999-1005 (Pubmed Abstract, PDF)

The effects of mesenchymal stem cells on lymphoblastic leukemia cell proliferation
Vildan Bozok Cetintas, Huseyin Aktug, Fatih Oltulu, Ahmet Keskinoglu, Buket Erer Del Castello, Dilek Taskiran; pp 1006-1017 (Pubmed Abstract, PDF)

LUNG CANCER

Pleural fluid glucose: A predictor of unsuccessful pleurodesis in a preselected cohort of patients with malignant pleural effusion
Ioannis Pantazopoulos, Theodoros Xanthos, Ioannis Vlachos, Zacharias Kakoulas, Konstantinos Stroumpoulis, Athanasios Chalkias, Georgios Tsoukalas, Antonia Koutsoukou; pp 1018-1023 (Pubmed Abstract, PDF)

The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence
Milena Cavic, Ana Krivokuca, Jelena Spasic, Ksenija Brotto, Emina Malisic, Davorin Radosavljevic, Sinisa Radulovic, Radmila Jankovic; pp 1024-1028 (Pubmed Abstract, PDF)

CNS TUMORS

Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas
Kemal Ekici, Naciye Ozseker, Alpaslan Mayadagli, Mihriban Erdogan Kocak, Ali Olmezoglu; pp 1029-1034 (Pubmed Abstract, PDF)

Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence
Ozge Gumusay, Bulent Cetin, Ahmet Ozet, Umut Demirci, Suleyman Buyukberber, Ugur Coskun, Efnan Algin, Aytug Uner, Ramazan Yildiz, Gokhan Kurt, Mustafa Benekli; pp 1035-1040 (Pubmed Abstract, PDF)

HEPATOCELLULAR CARCINOMA

Promoter methylation assay of SASH1 gene in hepatocellular carcinoma
Liu peng, He wei, Li liren; pp 1041-1047 (Pubmed Abstract, PDF)

Cytotoxic effects of suramin against HepG2 cells through activation of intrinsic apoptotic pathway
Ahmed Tayel, Mohamed A Ebrahim, Ahmed S Ibrahim, Amal M El-Gayar, Mohammed M Al-Gayyar; pp 1048-1054 (Pubmed Abstract, PDF)

PROSTATE CANCER

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines
Ahmet Dirican, Cigdem Erten, Harika Atmaca, Emir Bozkurt, Yuksel Kucukzeybek, Umut Varol, Mustafa Oktay Tarhan, Burcak Karaca, Ruchan Uslu; pp 1055-1061 (Pubmed Abstract, PDF)

RENAL CELL CARCINOMA

Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience
Onur Esbah, Umut Demirci, Kaan Helvaci, Fatma Paksoy Turkoz, Ahmet Siyar Ekinci, Ozlem Uysal Sonmez, Umugul Uyeturk, Ibrahim Turker, Tahsin Ozatli, Berna Oksuzoglu; pp 1062-1069 (Pubmed Abstract, PDF)

CHILDHOOD NEOPLASIA

Chemotherapy-related toxicity in childhood neoplasia
Ingrid Miron, Stefana Maria Moisa, Laurentiu Lucaci, Catalina Arsenescu-Georgescu, Lucian Miron, Anamaria Ciubara, Marin Burlea; pp 1070-1075 (Pubmed Abstract, PDF)

GASTRIC CANCER

The effects of environmental and dietary factors on the development of gastric cancer
Mustafa Karagulle, Evren Fidan, Halil Kavgaci, Feyyaz Ozdemir; pp 1076-1082 (Pubmed Abstract, PDF)

CANCER PAIN

Samarium-153Sm-EDTMP as an equivalent variant to pharmaceutical analgesic treatment
Gregory Tsoucalas, Eleni Sarafianou, Antonios Galanos, Efi Parpa, Nikolaos Baziotis, Markos Sgantzos, Vassiliki Gennimata, Maria Lymperi, Elisavet Patiraki, Vasilios Kouloulias, Kyriaki Mystakidou; pp 1083-1091 (Pubmed Abstract, PDF)

POLYMORPHISMS

Quantitative assessment of the association between GNB3 C825T polymorphism and cancer risk
Yong Wang, Shulong Zhang; pp 1092-1095 (Pubmed Abstract, PDF)

Genetic G2548A polymorphism of leptin gene and risk of cancer: a meta-analysis of 6860 cases and 7956 controls
Yunji Yang, Pengcheng Liu, Feng Guo, Run Liu, Yong Yang, Changjia Huang, Hexi Shu, Jinpeng Gong, Ming Cai; pp 1096-1104 (Pubmed Abstract, PDF)

RADIOTHERAPY TECHNIQUES

Impact of energy variation on Cone Ratio, PDD10, TMR2010 and IMRT doses for flattening filter free (FFF) beam of TomoTherapy Hi-ArtTM machines
Ranjini P Tolakanahalli, Dinesh K Tewatia; pp 1105-1110 (Pubmed Abstract, PDF)

SPECIAL ARTICLE

Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin’s lymphoma
Mihajlo Jakovljevic, Florian Gutzwiller, Matthias Schwenkglenks, Olivera Milovanovic, Nemanja Rancic, Mirjana Varjacic, Dobrivoje Stojadinovic, Aleksandar Dagovic, Klazien Matter-Walstra; pp 1111-1120 (Pubmed Abstract, PDF)
SHORT COMMUNICATION

Immunohistochemical expression of p53, p63, c-myc, p21WAF1/cip1 and p27kip1 proteins in urothelial bladder carcinoma: correlation with clinicopathological parameters
Dimitra Grapsa, Anna Dokou, Vassiliki Tsokanou-Kouli, Serafim Kaltsas, Eleftheria Dalakou, Rodoula Trigidou, Muhammad W. Saif, Ekaterini Politi; pp 1121-1124 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Anaplastic variant of diffuse large B-cell lymphoma associated with cutaneous fistulas; an unusual presentation
Gulsum Emel Pamuk, Murat Tasci, Mehmet Sevki Uyanik, Mustafa Akker, Fulya Oz Puyan; pp 1125-1129 (Pubmed Abstract, PDF)

Alternative oncological treatment: Psychological support for cancer patients – means for a better quality of life or better survival
Nebosja Ivanovic, Darko Zdravkovic; pp 1125-1129 (Pubmed Abstract, PDF)

Acute erythroid leukemia in a patient with chronic lymphocytic leukemia
Deniz C. Guven, Taner Babacan, Furkan Sarici, Serkan Akin, Kadri Altundag, Alev Turker; pp 1125-1129 (Pubmed Abstract, PDF)

Management of primary ovarian malignant fibrous histiocytoma
Havva Yesil Cinkir, Umut Demirci, Berna Okzusoglu, Necati Alkis; pp 1125-1129 (Pubmed Abstract, PDF)

Gastric cancer with diffuse hepatic metastases and complete radiological response to triplet chemotherapy
Umut Varol, Ahmet Alacacioglu, Ibrahim Yildiz, Yuksel Kucukzeybek, Ruchan Uslu; pp 1125-1129 (Pubmed Abstract, PDF)

CORRESPONDENCE

Comment on Zhao et al. article: IL-17A G197A and IL-17F T7488C polymorphisms and cancer risk in Asian populations: a meta-analysis
Chun Liu, Rong Xia; pp 1130-1132 (Pubmed Abstract, PDF)
Comment on Liu et al.’s article: “The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation?”
H. Moschouris, A.Papadatou, K.Malagari; pp 1130-1132 (Pubmed Abstract, PDF)
HISTORY OF ONCOLOGY
Charles-Emile Troisier (1844-1919) and the clinical description of signal node
Marianna Karamanou, Konstantinos Laios, Gregory Tsoucalas, Nikolaos Machairas, George Androutsos; pp 1133-1135 (Pubmed Abstract, PDF)